Literature DB >> 30975593

"Towards eliminating viral hepatitis": Examining the productive capacity and constitutive effects of global policy on hepatitis C elimination.

Kari Lancaster1, Tim Rhodes2, Jake Rance3.   

Abstract

In 2016 the World Health Organization published the first global health strategy to address viral hepatitis, setting a goal of eliminating viral hepatitis as a major public health threat by 2030. While the field has been motivated by this goal, to date there has been little critical attention paid to the productive capacity and constitutive effects of this policy. How is governing taking place through the mechanism of this global strategy, and how are its goals and targets shaping what is made thinkable (indeed, what is made as the real) about hepatitis C and its elimination? And with what effects? Taking the Global Health Sector Strategy on Viral Hepatitis, 2016-2021 as a text for analysis, we draw on poststructural thinking on problematisation and governmental technologies to examine how 'elimination' - as a proposal - constitutes the problem of hepatitis C. We critically consider the conceptual logics underpinning the elimination goal and targets, and the multiple material-discursive effects of this policy. We examine how governing takes place through numbers, by analysing 'target-setting' (and its accompanying practices of management, quantification and surveillance) as governmental technologies. We consider how the goal of elimination makes viral hepatitis visible and amenable to structuring, action and global management. Central to making viral hepatitis visible and manageable is quantification. Viral hepatitis is made as a problem requiring urgent global health management not through the representation of its effects on bodies or situated communities but rather through centralising inscription practices and comparison of estimated rates. It is important to remain alert to the multiple makings of hepatitis C and draw attention to effects which might be obscured due to a primary focus on quantification and management. To do so is to recognise the ontopolitical effects of governmental technologies, especially for communities 'targeted' by these strategies (including people who inject drugs).
Copyright © 2019 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Elimination; Governing through numbers; Hepatitis C; Ontological politics; Problematisation; Targets

Mesh:

Year:  2019        PMID: 30975593     DOI: 10.1016/j.drugpo.2019.02.008

Source DB:  PubMed          Journal:  Int J Drug Policy        ISSN: 0955-3959


  3 in total

1.  Hepatitis C cure as a 'gathering': Attending to the social and material relations of hepatitis C treatment.

Authors:  Adrian Farrugia; Renae Fomiatti; Suzanne Fraser; David Moore; Michael Edwards; Elizabeth Birbilis; Carla Treloar
Journal:  Sociol Health Illn       Date:  2022-04-01

2.  Determining the lower limit of detection required for HCV viral load assay for test of cure following direct-acting antiviral-based treatment regimens: Evidence from a global data set.

Authors:  Jake R Morgan; Elizabeth Marsh; Alexandra Savinkina; Sonjelle Shilton; Shaun Shadaker; Tengiz Tsertsvadze; George Kamkamidze; Maia Alkhazashvili; Timothy Morgan; Pam Belperio; Lisa Backus; Waheed Doss; Gamal Esmat; Mohamed Hassany; Aisha Elsharkawy; Wafaa Elakel; Mai Mehrez; Graham R Foster; Constance Wose Kinge; Kara W Chew; Charles S Chasela; Ian M Sanne; Yin M Thanung; Anne Loarec; Khawar Aslam; Suna Balkan; Philippa J Easterbrook; Benjamin P Linas
Journal:  J Viral Hepat       Date:  2022-03-30       Impact factor: 3.517

3.  Outreach onsite treatment with a simplified pangenotypic direct-acting anti-viral regimen for hepatitis C virus micro-elimination in a prison.

Authors:  Chun-Ting Chen; Ming-Ying Lu; Meng-Hsuan Hsieh; Pei-Chien Tsai; Tsai-Yuan Hsieh; Ming-Lun Yeh; Ching-I Huang; Yi-Shan Tsai; Yu-Min Ko; Ching-Chih Lin; Kuan-Yu Chen; Yu-Ju Wei; Po-Yao Hsu; Cheng-Ting Hsu; Tyng-Yuan Jang; Ta-Wei Liu; Po-Cheng Liang; Ming-Yen Hsieh; Zu-Yau Lin; Chung-Feng Huang; Jee-Fu Huang; Chia-Yen Dai; Wan-Long Chuang; Yu-Lueng Shih; Ming-Lung Yu
Journal:  World J Gastroenterol       Date:  2022-01-14       Impact factor: 5.742

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.